Renal Replacement Therapy in Patients With Stage IV Cancer Admitted to the Intensive Care Unit With Acute Kidney Injury at a Comprehensive Cancer Center Was Not Associated With Survival | Zendy

Ala Abudayyeh | Zendy; Juhee Song | Zendy; Maen Abdelrahim | Zendy; Ibrahim Dahbour | Zendy; Valda D. Page | Zendy; Shouhao Zhou | Zendy; Chan Shen | Zendy; Bo Zhao | Zendy; Rima Pai | Zendy; Jaya AmaramDavila | Zendy; Joanna-Grace M. Manzano | Zendy; Marina George | Zendy; Sriram Yennu | Zendy; Sreedhar Mandayam | Zendy; Joseph L. Nates | Zendy; Alvin H. Moss | Zendy

Open Access

Renal Replacement Therapy in Patients With Stage IV Cancer Admitted to the Intensive Care Unit With Acute Kidney Injury at a Comprehensive Cancer Center Was Not Associated With Survival

Author(s) -

Ala Abudayyeh,

Juhee Song,

Maen Abdelrahim,

Ibrahim Dahbour,

Valda D. Page,

Shouhao Zhou,

Chan Shen,

Bo Zhao,

Rima Pai,

Jaya AmaramDavila,

Joanna-Grace M. Manzano,

Marina George,

Sriram Yennu,

Sreedhar Mandayam,

Joseph L. Nates,

Alvin H. Moss

Publication year - 2020

Publication title -

american journal of hospice and palliative medicine®

Language(s) - English

Resource type - Journals

eISSN - 1938-2715

pISSN - 1049-9091

DOI - 10.1177/1049909120902115

Subject(s) - medicine , renal replacement therapy , acute kidney injury , intensive care unit , cancer , stage (stratigraphy) , center (category theory) , intensive care medicine , kidney cancer , oncology , paleontology , chemistry , biology , crystallography

In patients with advanced cancer, prolongation of life with treatment often incurs substantial emotional and financial expense. Among hospitalized patients with cancer since acute kidney injury (AKI) is known to be associated with much higher odds for hospital mortality, we investigated whether renal replacement therapy (RRT) use in the intensive care unit (ICU) was a significant independent predictor of worse outcomes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research